RxDoctor Payments Data

Samuel Dominguez

Pediatric Infectious Diseases · Aurora, CONPI 1629124227

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $13,744 of the $20,714 with a category attached, or 66.4%. 5 manufacturers reported payments, led by Diasorin Molecular LLC at 44.4% of the total. Reporting peaked in 2020 at $9,200 and has fallen 50.3% since, to $4,568 in 2025.

$20,714in general payments, 2019–2025

Across 13 payments — averaging $1593.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Diasorin Molecular LLC$9K
  • Biofire Diagnostics, LLC$7K
  • Roche Diagnostics Corporation$5K
  • Biomerieux Inc$24
  • Abbott$13
$476,603in research payments, 2019–2025

Across 12 payments — averaging $39,717 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biofire Diagnostics, LLC$477K

What the payments were for

  • Consulting fees$13,74466%
  • Speaking & faculty fees$5,35026%
  • Travel & lodging$9865%
  • Food & beverage$6343%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,714 in reported general payments places this provider in the 80th percentile of 20 pediatric infectious diseases providers in Colorado.

See all pediatric infectious diseases providers in Colorado

Other pediatric infectious diseases in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →